Hu Guoyan

415 total citations
9 papers, 258 citations indexed

About

Hu Guoyan is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Hu Guoyan has authored 9 papers receiving a total of 258 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Physiology and 2 papers in Pharmacology. Recurrent topics in Hu Guoyan's work include Alzheimer's disease research and treatments (3 papers), Medicinal Plants and Neuroprotection (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Hu Guoyan is often cited by papers focused on Alzheimer's disease research and treatments (3 papers), Medicinal Plants and Neuroprotection (2 papers) and Cholinesterase and Neurodegenerative Diseases (2 papers). Hu Guoyan collaborates with scholars based in China and United States. Hu Guoyan's co-authors include Xin Yang, Jun Zhao, Ou Shuai, Diling Chen, Xiaocui Tang, Guoxiao Lai, Ting Liu, Yizhen Xie, Jian Yang and Hongbo He and has published in prestigious journals such as PLoS ONE, Journal of Neurochemistry and Journal of Affective Disorders.

In The Last Decade

Hu Guoyan

9 papers receiving 253 citations

Peers

Hu Guoyan
Comparison fields: 5 of 69
  • Physiology 119
  • Molecular Biology 100
  • Biological Psychiatry 66
  • Psychiatry and Mental health 43
  • Neurology 33
Replace Hee Jae Lee with:
Hee Jae Lee South Korea
Enzo Emanuele Spain
Michiharu Nagahama Japan
Emily Connell United Kingdom
Sara Ruga Italy
Julia Doroszkiewicz Poland
Gül Özbey Türkiye
Paola Bisceglia Italy
Rebecca Galla Italy
Alexandre Francisco Solano Brazil
Hee Jae Lee South Korea View profile →
Citations per field, relative to Hu Guoyan
Hu Guoyan · 1×
Citations per year, relative to Hu Guoyan
Hu Guoyan · 1×

Countries citing papers authored by Hu Guoyan

Since Specialization
Citations

This map shows the geographic impact of Hu Guoyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hu Guoyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hu Guoyan more than expected).

Fields of papers citing papers by Hu Guoyan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hu Guoyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hu Guoyan. The network helps show where Hu Guoyan may publish in the future.

Co-authorship network of co-authors of Hu Guoyan

This figure shows the co-authorship network connecting the top 25 collaborators of Hu Guoyan. A scholar is included among the top collaborators of Hu Guoyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hu Guoyan. Hu Guoyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
# Work Indexed citations
1 41
2 9
3 12
4 9
5 87
6 35
7 53
8 10
9
[Clinical significance of determination of serum B7-H4 in patients with malignant hematologic diseases].
2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026